Better Buy: Alnylam Pharmaceuticals vs. Vir Biotechnology [The Motley Fool]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: The Motley Fool
Alnylam Pharmaceuticals(NASDAQ:ALNYVir BiotechnologyNASDAQ:VIRWith both of these biotechs at the forefront of the most important health issue of our time, which stock is a better buy? Let's find out.Image source: Getty Images.Differing R&D strategiesAlnylam's efforts to develop RNA interference (RNAi) based therapeutics date back to 00. RNAi seeks to silence genes by interfering with RNA, the blueprint the cells need to make specific proteins, involved with a particular disease. It has been a long, arduous path to translate this powerful technology into a therapy. Give credit to Alnylam for sticking with it. Sixteen years after its founding, Alnylam finally secured its first RNAi drug approval in August 08 from the Food and Drug Administration (FDA). In November 09, Alnylam scored its second FDA drug approval.Vir, founded in April 06, has sprinted toward its goals over recent years. Rather than focusing on a singular technology like Alnylam, Vir's mission squarely focuses on eradicati
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Do Alnylam Pharmaceuticals' (ALNY) Board Moves Quietly Reframe Its Management Incentives and Risk Profile? [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals Announces Changes to Board of DirectorsBusiness Wire
- Spotlight On Alnylam Pharmaceuticals And 2 Other Stocks Possibly Trading Below Fair Value [Yahoo! Finance]Yahoo! Finance
- Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3 [Seeking Alpha]Seeking Alpha
- Alnylam Pharmaceuticals (ALNY): Assessing Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 10/30/25 - Beat
ALNY
Sec Filings
- 12/3/25 - Form 8-K
- 12/1/25 - Form 4
- 11/19/25 - Form 4
- ALNY's page on the SEC website